Skip to content

magnesium(2+)/Finding

One finding, on its own

A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.

  • magnesium(2+) — decreases fasting blood glucose

    Evidence strength: very limited.Findingreplicated ×11
    “Overall, compared with placebo in gestational diabetes, magnesium supplementation was associated with significantly reduced fasting plasma glucose (standard mean difference [SMD] = -0.99; 95% confidence interval [CI] = -1.28 to -0.70; p < .00001), serum insulin (SMD = -0.75; 95% CI = -1.24 to -0.26; p = .003), homeostasis model assessment of insulin resistance (SMD = -0.74; 95% CI = -1.10 to -0.39; p < .0001) and increased quantitative insulin sensitivity check index (SMD = 0.47; 95% CI = 0.12 to 0.82; p = .008).”
    Quoted verbatim from Magnesium supplementation for glycemic status in women with gestational diabetes: a systematic review and meta-analysis..
    Study
    meta-analysis
    Population
    Women with gestational diabetes; four randomised controlled trials pooled

    Effect -0.99 standardised mean difference, 95% CI -1.28 to -0.7

    Magnesium supplementation for glycemic status in women with gestational diabetes: a systematic review and meta-analysis.2022PMID:3490782010.1080/09513590.2021.1988558Permalink

To cite this finding: https://catalystproject.ai/e/01M5N3J38GR9K2NQYHB1XR5VT6

Keep reading